1. Li, Yun, Liu, Chenying, Zhang, Xin, Xing, Feiyue, Tian, Han. 2022. CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/β-catenin signalling pathway. In British journal of cancer, 126, 1684-1694. doi:10.1038/s41416-022-01747-0. https://pubmed.ncbi.nlm.nih.gov/35194191/
2. Meng, Yiliang, Yang, Liu, Wei, Xiao, Yu, Guifang, Luo, Qisheng. 2021. CCT5 interacts with cyclin D1 promoting lung adenocarcinoma cell migration and invasion. In Biochemical and biophysical research communications, 567, 222-229. doi:10.1016/j.bbrc.2021.04.105. https://pubmed.ncbi.nlm.nih.gov/34217974/
3. Pla-Prats, Carlos, Cavadini, Simone, Kempf, Georg, Thomä, Nicolas H. 2023. Recognition of the CCT5 di-Glu degron by CRL4DCAF12 is dependent on TRiC assembly. In The EMBO journal, 42, e112253. doi:10.15252/embj.2022112253. https://pubmed.ncbi.nlm.nih.gov/36715408/
4. Wu, Shaoyu, Peng, Lingrong. . Increased CCT5 expression is a potential unfavourable factor promoting the growth of nasopharyngeal carcinoma. In The Journal of international medical research, 52, 3000605241271754. doi:10.1177/03000605241271754. https://pubmed.ncbi.nlm.nih.gov/39286844/
5. Fink, John K. 2013. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. In Acta neuropathologica, 126, 307-28. doi:10.1007/s00401-013-1115-8. https://pubmed.ncbi.nlm.nih.gov/23897027/
6. Righetto, Germanna Lima, Yin, Yanting, Duda, David M, Santhakumar, Vijayaratnam, Halabelian, Levon. 2024. Probing the CRL4DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons. In PNAS nexus, 3, pgae153. doi:10.1093/pnasnexus/pgae153. https://pubmed.ncbi.nlm.nih.gov/38665159/
7. Xu, Jingjing, Zhang, Yuan, Liu, Cheng, Yan, Ping, Yang, Zongguo. 2021. Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis. In International journal of medical sciences, 18, 3556-3564. doi:10.7150/ijms.57504. https://pubmed.ncbi.nlm.nih.gov/34522182/
智鼠故事 
